Stand Up To Cancer and SandboxAQ Collaborate on AI-Driven Cancer Research
Stand Up To Cancer and SandboxAQ have announced a collaboration to integrate SandboxAQ's Large Quantitative Models (LQMs) into cancer research projects funded by Stand Up To Cancer. Announced in a press release, this initiative aims to accelerate the development of new treatments by leveraging advanced AI and data modeling tools.
The collaboration will focus on supporting high-impact cancer research, including efforts to detect hard-to-diagnose cancers and optimize treatment responses. By using SandboxAQ's AI technology, the initiative seeks to find early warning signs of disease and create personalized treatment strategies.
Julian Adams, Ph.D., president and CEO of Stand Up To Cancer, emphasized the potential of this partnership to catch cancer earlier and treat it more precisely. Jack Hidary, CEO of SandboxAQ, expressed excitement about using their AI LQM platform to model complex biological systems and accelerate oncology research.
This collaboration aligns with Stand Up To Cancer's goal to decrease cancer mortality significantly over the next decade by making early-stage cancer detection a standard of care. More details about the specific research teams involved will be announced as fundraising milestones are reached.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 22 BioStack Raises $9.5 Million for Medical AI Data Network Oct 22 Warp Sciences Raises $215 Million to Automate Drug Discovery Labs Oct 22 FDA Clears RIVANNA BoneEnhance Software for Accuro XV Oct 22 Tufts Medicine Uses Humata Health to Automate Prior Authorization Oct 22 HHS Plans Sole Source Claude Contract With AnthropicLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
AstraZeneca and Oracle Partner on AI for Clinical Trials
INmune Bio and QCi Apply Quantum Computing to XPro Research
Likang to Present AI Cancer Immunotherapy Platform in Abu Dhabi
SAS and NC State Launch AI Research Partnership
Daily AI Brief: the AI news that matters, in your inbox.